James Bird is an experienced professional in the pharmaceutical industry with a strong background in drug metabolism and pharmacokinetics (DMPK). During tenure at AstraZeneca from August 2015 to October 2017, James held various positions including DMPK Design Leader, Modeling and Simulation Scientist, and Director of DMPK, as well as a role as Acting Team Leader in ADME from October 2017 to September 2018. Prior experience includes serving as a Research Scientist at Prosidion Ltd from January 2005 to June 2006. James holds a Master of Chemistry (MChem) degree in Chemistry from Sheffield University, completed between 1999 and 2003.
This person is not in the org chart
This person is not in any teams
This person is not in any offices